Pharma company Lupin has entered into agreement with DSM Anti-Infectives for strategic cooperation in the cephalosporins segment.
Pharma company Lupin said on Friday that it has entered into supply and marketing agreement with DSM Anti-Infectives India Ltd for a strategic cooperation in the cephalosporins segment.
HT Image
"This strategic cooperation will further enable the companies to strengthen their respective positions in this segment through enhanced utilisation of existing resources, with an enhanced market access," Lupin said in a release at Mumbai.
"This development enhances our market reach and will enable us to optimally utilise our resources. We look forward to increase this cooperation over a wider product basket to bring synergetic advantages to both Lupin and DSM Anti-Infectives," Satish Khanna, Group President API, Lupin Limited said.